Aratana: 3Q Earnings Snapshot

LEAWOOD, Kan. (AP) _ Aratana Therapeutics Inc. (PETX) on Thursday reported third-quarter net income of $8.8 million, after reporting a loss in the same period a year earlier.

On a per-share basis, the Leawood, Kansas-based company said it had profit of 19 cents.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share.

The developer of pet medications posted revenue of $21.6 million in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $5.7 million.

Aratana shares have risen 20 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $6.33, a rise of 12 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PETX at https://www.zacks.com/ap/PETX